Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $5.0900 (-15.31%) ($5.0600 - $5.9600) on Mon. Jun. 29, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.39% (three month average) | RSI | 26 | Latest Price | $5.0900(-15.31%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ANPC declines -5.7% a day on average for past five trading days. | Weekly Trend | ANPC declines -6.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) XLB(11%) PCY(10%) HYG(9%) LIT(9%) IPO(8%) | Factors Impacting ANPC price | ANPC will decline at least -2.195% in a week (0% probabilities). SHY(-20%) XBI(-8%) IBB(-8%) XLP(-6%) IGOV(-6%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.195% (StdDev 4.39%) | Hourly BBV | 0 () | Intraday Trend | -14.6% | | | |
|
1 - 5 Day Possible Target | $-9.47(-286.05%) | Resistance Level | $6.94 | 5 Day Moving Average | $6.25(-18.56%) | 10 Day Moving Average | $6.63(-23.23%) | 20 Day Moving Average | $6.94(-26.66%) | To recent high | -40% | To recent low | 0% | Market Cap | $43m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |